TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 85 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $252,000 | -7.0% | 6,966 | +11.2% | 0.00% | – |
| Q1 2022 | $271,000 | -13.7% | 6,266 | 0.0% | 0.00% | – |
| Q4 2021 | $314,000 | -21.3% | 6,266 | 0.0% | 0.00% | – |
| Q3 2021 | $399,000 | -11.5% | 6,266 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $451,000 | -52.8% | 6,266 | -51.7% | 0.00% | 0.0% |
| Q1 2021 | $956,000 | +114.8% | 12,966 | +113.7% | 0.00% | 0.0% |
| Q4 2020 | $445,000 | -37.4% | 6,066 | -53.2% | 0.00% | 0.0% |
| Q3 2020 | $711,000 | -17.5% | 12,966 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $862,000 | +8.6% | 12,966 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $794,000 | -30.4% | 12,966 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $1,140,000 | -36.4% | 12,966 | -45.4% | 0.00% | -50.0% |
| Q3 2019 | $1,793,000 | -11.7% | 23,766 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $2,030,000 | -21.0% | 23,766 | 0.0% | 0.00% | -20.0% |
| Q1 2019 | $2,569,000 | +28.3% | 23,766 | +0.4% | 0.01% | +25.0% |
| Q4 2018 | $2,003,000 | -50.7% | 23,666 | -42.7% | 0.00% | -50.0% |
| Q3 2018 | $4,062,000 | +13.5% | 41,326 | +33.5% | 0.01% | +14.3% |
| Q2 2018 | $3,580,000 | -12.3% | 30,949 | -25.1% | 0.01% | 0.0% |
| Q1 2018 | $4,081,000 | -21.6% | 41,326 | -16.9% | 0.01% | -30.0% |
| Q4 2017 | $5,207,000 | +6250.0% | 49,726 | +6749.3% | 0.01% | – |
| Q3 2017 | $82,000 | +1.2% | 726 | 0.0% | 0.00% | – |
| Q2 2017 | $81,000 | -98.6% | 726 | -98.5% | 0.00% | -100.0% |
| Q1 2017 | $5,799,000 | +450.7% | 49,726 | +397.3% | 0.02% | +275.0% |
| Q4 2016 | $1,053,000 | +376.5% | 10,000 | +400.0% | 0.00% | +300.0% |
| Q3 2016 | $221,000 | -24.1% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $291,000 | -79.7% | 2,000 | -80.0% | 0.00% | -83.3% |
| Q1 2016 | $1,433,000 | -7.3% | 10,000 | 0.0% | 0.01% | -14.3% |
| Q4 2015 | $1,546,000 | -70.6% | 10,000 | -72.8% | 0.01% | -68.2% |
| Q3 2015 | $5,258,000 | +19.2% | 36,800 | +19.9% | 0.02% | +57.1% |
| Q2 2015 | $4,411,000 | -13.1% | 30,700 | -14.7% | 0.01% | -26.3% |
| Q1 2015 | $5,077,000 | -4.8% | 36,000 | 0.0% | 0.02% | +11.8% |
| Q4 2014 | $5,335,000 | -9.2% | 36,000 | -5.8% | 0.02% | -19.0% |
| Q3 2014 | $5,877,000 | +20.4% | 38,200 | +9.8% | 0.02% | +23.5% |
| Q2 2014 | $4,880,000 | +26.3% | 34,800 | 0.0% | 0.02% | +13.3% |
| Q1 2014 | $3,863,000 | +12.2% | 34,800 | 0.0% | 0.02% | +7.1% |
| Q4 2013 | $3,442,000 | +151.6% | 34,800 | +93.3% | 0.01% | +133.3% |
| Q3 2013 | $1,368,000 | – | 18,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |